|
DDB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44249065417534E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55111512312578E-16 |
| Normal-vs-Stage2 |
1.96465999999784E-05 |
| Normal-vs-Stage3 |
1.343440E-03 |
| Normal-vs-Stage4 |
6.597200E-04 |
| Stage1-vs-Stage2 |
7.773200E-01 |
| Stage1-vs-Stage3 |
1.625990E-01 |
| Stage1-vs-Stage4 |
6.618600E-01 |
| Stage2-vs-Stage3 |
4.580600E-01 |
| Stage2-vs-Stage4 |
5.395200E-01 |
| Stage3-vs-Stage4 |
2.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.77635683940025E-15 |
| Normal-vs-AfricanAmerican |
5.89330029221458E-10 |
| Normal-vs-Asian |
3.170300E-02 |
| Caucasian-vs-AfricanAmerican |
7.798400E-01 |
| Caucasian-vs-Asian |
9.166800E-01 |
| AfricanAmerican-vs-Asian |
8.371800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.230000E-04 |
| Male-vs-Female |
3.85980000000563E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.85910000003198E-06 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
3.05289999946723E-08 |
| Normal-vs-Extreme_Obese |
1.023370E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.357500E-02 |
| Normal_Weight-vs-Obese |
9.853800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.324200E-01 |
| Extreme_Weight-vs-Obese |
7.255300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.446600E-01 |
| Obese-vs-Extreme_Obese |
2.735200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.049440E-01 |
| Normal-vs-Age(41-60Yrs) |
5.50115508701765E-13 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
8.03630000000277E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.412840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.187600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.165200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.539800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.885400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.77589998262562E-09 |
| Normal-VS-KIRP CIMP |
8.383600E-01 |
| Normal-VS-Unclassified PRCC |
1.404250E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.354010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.448000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.384400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.120200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.118200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.812400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.94826443445618E-12 |
| Normal-vs-N1 |
9.084200E-03 |
| Normal-vs-N2 |
1.771850E-01 |
| N0-vs-N1 |
1.164020E-01 |
| N0-vs-N2 |
6.922400E-01 |
| N1-vs-N2 |
6.894200E-01 |
|
|
